Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
27.5%
% of HRTS's 41 holdings also in HART
16.7%
% of HART's 75 holdings also in HRTS
Overlap by Weight
Sector Drift (HRTS minus HART)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in HART |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.9% | 5.4% | 5.4% |
|
ABBOTT LABORATORIES | 4.0% | 5.7% | 4.0% |
 |
ASTRAZENECA PLC | 4.0% | 5.6% | 4.0% |
 |
NOVO NORDISK A/S-B | 3.9% | 4.0% | 3.9% |
 |
NOVARTIS AG | 3.1% | 5.3% | 3.1% |
Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to HART
|
UNITEDHEALTH GROUP INC | 5.6% |
|
ELI LILLY & CO | 5.6% |
|
BRIDGEBIO PHARMA, INC. | 4.3% |
|
ROCHE HOLDINGS LTD-SPONS ADR | 3.9% |
|
VERTEX PHARMACEUTICALS INC | 3.6% |
|
GILEAD SCIENCES INC | 3.1% |
|
THERMO FISHER SCIENTIFIC INC | 2.8% |
|
CRINETICS PHARMACEUTICALS INC | 2.8% |
|
MERCK & CO. INC. | 2.5% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 2.3% |
HRTS Underweight Relative to HART
|
JOHNSON & JOHNSON | -5.3% |
|
ALPHABET INC. CLASS A | -5.0% |
|
PFIZER INC | -5.0% |
|
APPLE INC | -4.9% |
 |
SANOFI-AVENTIS | -4.0% |
|
ELEVANCE HEALTH INC | -2.8% |
|
BRISTOL-MYERS SQUIBB CO | -2.8% |
|
NIKE INC -CL B | -2.7% |
 |
MEDTRONIC PLC | -2.4% |
|
BOSTON SCIENTIFIC CORP | -2.3% |